Kidney Transplant clinical trials at UC Cancer
1 research study open to eligible people
open to eligible people ages 18-70
The primary objective of this study is to demonstrate the safety and efficacy of cellular immunotherapy with MDR-101 for induction of functional immune tolerance in recipients of human leukocyte antigen (HLA)-matched, living donor kidney transplants.
at UC Davis UCSD UCSF